Stockreport

NewAmsterdam Pharma to Participate in Upcoming Medical and Investor Conferences in November

NewAmsterdam Pharma Company N.V. - Ordinary Shares  (NAMS) 
PDF NAARDEN, The Netherlands and MIAMI, Oct. 28, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, [Read more]